↓ Skip to main content

Cochrane Database of Systematic Reviews

Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
7 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
108 Mendeley
Title
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia
Published in
Cochrane database of systematic reviews, July 2014
DOI 10.1002/14651858.cd009268.pub2
Pubmed ID
Authors

Magdolna Tardy, Maximilian Huhn, Werner Kissling, Rolf R Engel, Stefan Leucht

Abstract

Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between antipsychotic compounds, however, low-potency antipsychotic drugs are often clinically perceived as less efficacious than high-potency compounds, and they also seem to differ in their side-effects.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
South Africa 1 <1%
Unknown 105 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 19%
Student > Bachelor 14 13%
Researcher 13 12%
Student > Doctoral Student 10 9%
Student > Ph. D. Student 9 8%
Other 24 22%
Unknown 17 16%
Readers by discipline Count As %
Medicine and Dentistry 36 33%
Psychology 14 13%
Nursing and Health Professions 10 9%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Neuroscience 4 4%
Other 16 15%
Unknown 22 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2016.
All research outputs
#1,268,577
of 17,361,274 outputs
Outputs from Cochrane database of systematic reviews
#3,270
of 11,660 outputs
Outputs of similar age
#16,108
of 199,928 outputs
Outputs of similar age from Cochrane database of systematic reviews
#59
of 221 outputs
Altmetric has tracked 17,361,274 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,928 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 221 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.